This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vertex Pharmaceuticals Inc (VRTX)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -742.74M -687.55M -51.14M 41.18M
Operating Gains/Losses 0.00 0.00 390.00K 16.86M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 7.43M 53.36M 39.91M -170.61M
(Increase) Decrease in Inventories -16.47M 7.14M -29.92M -111.39M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 25.05M -49.23M 14.89M 37.47M
(Decrease) Increase In Other Current Liabilities 14.23M 48.75M 17.87M 125.62M
(Increase) Decrease In Other Working Capital -25.53M -53.01M -44.28M -72.44M
Other Non-Cash Items 177.07M 877.72M 257.52M 232.82M
Net Cash From Continuing Operations -513.20M -51.57M 267.84M 143.74M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -513.20M -51.57M 267.84M 143.74M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 1.56B 2.35B 1.37B 1.02B
Purchases of Property, Plant & Equipment -61.20M -51.39M -71.14M -94.60M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -1.42B -2.41B -1.71B -721.54M
Other Cash from Investing Activities 1.39M 61.39M -16.78M 12.51M
Cash Provided by Financing Activities
Net Cash From Investing Activities 73.96M -54.13M -425.82M 212.41M
Issuance of Debt 294.24M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 274.62M 265.88M 191.72M 124.86M
Repayment of Long-Term Debt -81.69M -83.74M -21.49M -250.00M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 10.21M -1.25M 1.97M 900.00K
Net Cash From Financing Activities 497.38M 180.88M 172.20M -124.24M
Effect of Exchange Rate Changes -2.18M 4.71M -141.00K 214.00K
Net Change in Cash & Cash Equivalents 55.96M 79.89M 14.09M 232.12M

VRTX Vertex Pharmaceuticals Inc

Chart of VRTX

Analysts Ratings for VRTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 7 7
Moderate Buy 2 1 1 1
Hold 8 10 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

VRTX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs